555 related articles for article (PubMed ID: 19268735)
1. Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation.
Roy P; Bonello L; Torguson R; Okabe T; Pinto Slottow TL; Steinberg DH; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
Am J Cardiol; 2009 Mar; 103(6):801-5. PubMed ID: 19268735
[TBL] [Abstract][Full Text] [Related]
2. The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents.
Butler MJ; Eccleston D; Clark DJ; Ajani AE; Andrianopoulos N; Brennan A; New G; Black A; Szto G; Reid CM; Yan BP; Shaw JA; Dart AM; Duffy SJ;
Am Heart J; 2009 May; 157(5):899-907. PubMed ID: 19376319
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
[TBL] [Abstract][Full Text] [Related]
4. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.
Wang ZJ; Zhou YJ; Liu YY; Yu M; Shi DM; Zhao YX; Guo YH; Cheng WJ; Jia de A; Cao Z; Nie B; Ge HL; Yang SW; Yan ZX
Thromb Res; 2009 May; 124(1):46-51. PubMed ID: 19041120
[TBL] [Abstract][Full Text] [Related]
5. [Optimal platelet inhibition after coronary stent implantation. Current status].
Silber S; Hoffmeister HM; Bode C
Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
[TBL] [Abstract][Full Text] [Related]
6. Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
Wolak A; Amit G; Cafri C; Gilutz H; Ilia R; Zahger D
Int J Cardiol; 2005 Sep; 103(3):293-7. PubMed ID: 16098392
[TBL] [Abstract][Full Text] [Related]
7. High residual platelet reactivity after clopidogrel loading and long-term clinical outcome after drug-eluting stenting for unprotected left main coronary disease.
Migliorini A; Valenti R; Marcucci R; Parodi G; Giuliani G; Buonamici P; Cerisano G; Carrabba N; Gensini GF; Abbate R; Antoniucci D
Circulation; 2009 Dec; 120(22):2214-21. PubMed ID: 19917884
[TBL] [Abstract][Full Text] [Related]
8. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents.
Kuchulakanti PK; Chu WW; Torguson R; Ohlmann P; Rha SW; Clavijo LC; Kim SW; Bui A; Gevorkian N; Xue Z; Smith K; Fournadjieva J; Suddath WO; Satler LF; Pichard AD; Kent KM; Waksman R
Circulation; 2006 Feb; 113(8):1108-13. PubMed ID: 16490815
[TBL] [Abstract][Full Text] [Related]
9. A high maintenance dose of clopidogrel improves short-term clinical outcomes in patients with acute coronary syndrome undergoing drug-eluting stent implantation.
Han YL; Wang B; Li Y; Xu K; Wang SL; Jing QM; Wang ZL; Wang DM; Ma YY; Wang G
Chin Med J (Engl); 2009 Apr; 122(7):793-7. PubMed ID: 19493391
[TBL] [Abstract][Full Text] [Related]
10. High maintenance dosage of clopidogrel is associated with a reduced risk of stent thrombosis in clopidogrel-resistant patients.
Tavassoli N; Voisin S; Carrie D; Lapeyre-Mestre M; Galinier M; Montastruc JL; Pathak A
Am J Cardiovasc Drugs; 2010; 10(1):29-35. PubMed ID: 20104932
[TBL] [Abstract][Full Text] [Related]
11. Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting.
Sibbing D; Morath T; Braun S; Stegherr J; Mehilli J; Vogt W; Schömig A; Kastrati A; von Beckerath N
Thromb Haemost; 2010 Jan; 103(1):151-9. PubMed ID: 20062919
[TBL] [Abstract][Full Text] [Related]
12. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis.
Buonamici P; Marcucci R; Migliorini A; Gensini GF; Santini A; Paniccia R; Moschi G; Gori AM; Abbate R; Antoniucci D
J Am Coll Cardiol; 2007 Jun; 49(24):2312-7. PubMed ID: 17572245
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis.
Pinto Slottow TL; Bonello L; Gavini R; Beauzile P; Sushinsky SJ; Scheinowitz M; Kaneshige K; Xue Z; Torguson R; Tantry U; Pichard AD; Satler LF; Suddath WO; Kent K; Gurbel P; Waksman R
Am J Cardiol; 2009 Aug; 104(4):525-30. PubMed ID: 19660606
[TBL] [Abstract][Full Text] [Related]
14. A more than 2-year follow-up of incomplete apposition after drug-eluting stent implantation.
Qian JY; Zhang F; Fan B; Ge L; Wang QB; Ge JB
Chin Med J (Engl); 2008 Mar; 121(6):498-502. PubMed ID: 18364132
[TBL] [Abstract][Full Text] [Related]
15. Reasonable duration of Clopidogrel use after drug-eluting stent implantation in Korean patients.
Shin DH; Chae IH; Youn TJ; Cho SI; Kwon DA; Suh JW; Chang HJ; Cho YS; Chung WY; Choi YJ; Gwon HC; Han KR; Choi DJ
Am J Cardiol; 2009 Dec; 104(12):1668-73. PubMed ID: 19962472
[TBL] [Abstract][Full Text] [Related]
16. New coating stent design for patients with high-risk coronary lesions for thrombotic events: early and long-term results of the Camouflage registry.
Perez G; Rodriguez-Granillo AM; Mieres J; Llaurado C; Rubilar B; Risau G; Fernandez-Pereira C; Rodriguez AE
J Invasive Cardiol; 2009 Aug; 21(8):378-82. PubMed ID: 19652248
[TBL] [Abstract][Full Text] [Related]
17. Impact of "nuisance" bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation.
Roy P; Bonello L; Torguson R; de Labriolle A; Lemesle G; Slottow TL; Steinberg DH; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
Am J Cardiol; 2008 Dec; 102(12):1614-7. PubMed ID: 19064014
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, predictors, and long-term prognosis of premature discontinuation of oral antiplatelet therapy after drug eluting stent implantation.
Rossini R; Capodanno D; Lettieri C; Musumeci G; Nijaradze T; Romano M; Lortkipanidze N; Cicorella N; Biondi Zoccai G; Sirbu V; Izzo A; Guagliumi G; Valsecchi O; Gavazzi A; Angiolillo DJ
Am J Cardiol; 2011 Jan; 107(2):186-94. PubMed ID: 21211596
[TBL] [Abstract][Full Text] [Related]
19. Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos).
de la Torre-Hernández JM; Alfonso F; Hernández F; Elizaga J; Sanmartin M; Pinar E; Lozano I; Vazquez JM; Botas J; Perez de Prado A; Hernández JM; Sanchis J; Nodar JM; Gomez-Jaume A; Larman M; Diarte JA; Rodríguez-Collado J; Rumoroso JR; Lopez-Minguez JR; Mauri J;
J Am Coll Cardiol; 2008 Mar; 51(10):986-90. PubMed ID: 18325436
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions.
Brar SS; Kim J; Brar SK; Zadegan R; Ree M; Liu IL; Mansukhani P; Aharonian V; Hyett R; Shen AY
J Am Coll Cardiol; 2008 Jun; 51(23):2220-7. PubMed ID: 18534267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
